HealthEquity, Inc. (NASDAQ:HQY) has been assigned an average rating of “Buy” from the fifteen ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating on the company. The average 1 year price objective among analysts that have covered the stock in the last year is $49.75.
A number of research firms have weighed in on HQY. Cantor Fitzgerald reaffirmed a “buy” rating and set a $56.00 price target on shares of HealthEquity in a research note on Tuesday. BidaskClub downgraded shares of HealthEquity from a “hold” rating to a “sell” rating in a research note on Thursday, August 3rd. Zacks Investment Research downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Friday, August 4th. Chardan Capital increased their price target on shares of HealthEquity from $53.00 to $57.00 and gave the stock a “buy” rating in a research note on Wednesday, June 7th. Finally, Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $61.00 price target (up previously from $57.00) on shares of HealthEquity in a research note on Monday, June 12th.
WARNING: “HealthEquity, Inc. (HQY) Given Consensus Recommendation of “Buy” by Analysts” was first posted by BBNS and is owned by of BBNS. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://baseballnewssource.com/markets/healthequity-inc-hqy-given-consensus-recommendation-of-buy-by-analysts/1565411.html.
Shares of HealthEquity (HQY) traded up 2.79% during mid-day trading on Friday, hitting $42.77. 620,338 shares of the stock were exchanged. HealthEquity has a one year low of $30.34 and a one year high of $54.95. The stock has a market cap of $2.57 billion, a PE ratio of 80.39 and a beta of 1.73. The company has a 50-day moving average of $46.03 and a 200 day moving average of $45.83.
HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.16 by $0.03. The company had revenue of $55.40 million for the quarter, compared to the consensus estimate of $54.77 million. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. HealthEquity’s revenue was up 25.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.15 earnings per share. On average, equities analysts predict that HealthEquity will post $0.59 earnings per share for the current year.
In related news, Director Frank Medici sold 537,102 shares of the firm’s stock in a transaction on Friday, July 14th. The shares were sold at an average price of $51.24, for a total transaction of $27,521,106.48. Following the completion of the sale, the director now directly owns 6,381 shares of the company’s stock, valued at approximately $326,962.44. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Ashley Dreier sold 10,000 shares of the firm’s stock in a transaction on Monday, June 5th. The shares were sold at an average price of $47.81, for a total transaction of $478,100.00. Following the sale, the vice president now directly owns 15,652 shares of the company’s stock, valued at $748,322.12. The disclosure for this sale can be found here. Insiders sold 2,483,821 shares of company stock valued at $127,137,793 in the last three months. Company insiders own 29.00% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in HealthEquity by 6.2% in the first quarter. Vanguard Group Inc. now owns 4,115,237 shares of the company’s stock worth $174,691,000 after buying an additional 240,136 shares during the last quarter. Paloma Partners Management Co purchased a new stake in HealthEquity during the first quarter worth $503,000. Glen Harbor Capital Management LLC raised its stake in HealthEquity by 0.4% in the first quarter. Glen Harbor Capital Management LLC now owns 43,956 shares of the company’s stock worth $1,866,000 after buying an additional 154 shares during the last quarter. Bank of America Corp DE raised its stake in HealthEquity by 57.6% in the first quarter. Bank of America Corp DE now owns 86,183 shares of the company’s stock worth $3,659,000 after buying an additional 31,500 shares during the last quarter. Finally, AQR Capital Management LLC raised its stake in HealthEquity by 635.3% in the first quarter. AQR Capital Management LLC now owns 53,178 shares of the company’s stock worth $2,257,000 after buying an additional 45,946 shares during the last quarter. 91.86% of the stock is owned by institutional investors and hedge funds.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with our FREE daily email newsletter.